bioAffinity Technologies Files 8-K Report
Ticker: BIAFW · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1712762
Sentiment: neutral
Topics: 8-K, filing, corporate-update
Related Tickers: BIAF
TL;DR
BIAF filed an 8-K on 7/15/25 covering other events and financials.
AI Summary
On July 15, 2025, bioAffinity Technologies, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217. The report covers 'Other Events' and 'Financial Statements and Exhibits'.
Why It Matters
This 8-K filing provides an update on bioAffinity Technologies' corporate events and financial disclosures, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not contain information about significant financial changes, acquisitions, or legal issues.
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Registrant
- July 15, 2025 (date) — Date of earliest event reported
- San Antonio, Texas (location) — Principal executive offices location
- 001-41463 (other) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' for bioAffinity Technologies, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 15, 2025.
Where are bioAffinity Technologies, Inc.'s principal executive offices located?
bioAffinity Technologies, Inc.'s principal executive offices are located at 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217.
What is the Commission File Number for bioAffinity Technologies, Inc.?
The Commission File Number for bioAffinity Technologies, Inc. is 001-41463.
What is the I.R.S. Employer Identification Number for bioAffinity Technologies, Inc.?
The I.R.S. Employer Identification Number for bioAffinity Technologies, Inc. is 46-5211056.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).